1
|
Anghel A, Stanisavljevic M, Andani S, Papandreou N, Rüschoff JH, Wild P, Gabrani M, Pozidis H. A High-Performance System for Robust Stain Normalization of Whole-Slide Images in Histopathology. Front Med (Lausanne) 2019; 6:193. [PMID: 31632974 PMCID: PMC6778842 DOI: 10.3389/fmed.2019.00193] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2019] [Accepted: 08/15/2019] [Indexed: 11/30/2022] Open
Abstract
Stain normalization is an important processing task for computer-aided diagnosis (CAD) systems in modern digital pathology. This task reduces the color and intensity variations present in stained images from different laboratories. Consequently, stain normalization typically increases the prediction accuracy of CAD systems. However, there are computational challenges that this normalization step must overcome, especially for real-time applications: the memory and run-time bottlenecks associated with the processing of images in high resolution, e.g., 40X. Moreover, stain normalization can be sensitive to the quality of the input images, e.g., when they contain stain spots or dirt. In this case, the algorithm may fail to accurately estimate the stain vectors. We present a high-performance system for stain normalization using a state-of-the-art unsupervised method based on stain-vector estimation. Using a highly-optimized normalization engine, our architecture enables high-speed and large-scale processing of high-resolution whole-slide images. This optimized engine integrates an automated thresholding technique to determine the useful pixels and uses a novel pixel-sampling method that significantly reduces the processing time of the normalization algorithm. We demonstrate the performance of our architecture using measurements from images of different sizes and scanner formats that belong to four different datasets. The results show that our optimizations achieve up to 58x speedup compared to a baseline implementation. We also prove the scalability of our system by showing that the processing time scales almost linearly with the amount of tissue pixels present in the image. Furthermore, we show that the output of the normalization algorithm can be adversely affected when the input images include artifacts. To address this issue, we enhance the stain normalization pipeline by introducing a parameter cross-checking technique that automatically detects the distortion of the algorithm's critical parameters. To assess the robustness of the proposed method we employ a machine learning (ML) pipeline that classifies images for detection of prostate cancer. The results show that the enhanced normalization algorithm increases the classification accuracy of the ML pipeline in the presence of poor-quality input images. For an exemplary ML pipeline, our new method increases the accuracy on an unseen dataset from 0.79 to 0.87.
Collapse
Affiliation(s)
| | | | | | | | - Jan Hendrick Rüschoff
- Institute of Pathology and Molecular Pathology, University Hospital Zürich, Zurich, Switzerland
| | - Peter Wild
- Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt, Germany
| | | | | |
Collapse
|
2
|
Anghel A, Bison G, Blau B, Daum M, Hild N, Kirch K, Lauss B, Ries D, Schmidt-Wellenburg P, Talanov V, Wohlmuther M, Zsigmond G. The ultracold neutron source at the Paul Scherrer Institute – Performance and status. JNR 2019. [DOI: 10.3233/jnr-180086] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- A. Anghel
- Paul Scherrer Institute, Villigen PSI, Switzerland
| | - G. Bison
- Paul Scherrer Institute, Villigen PSI, Switzerland
| | - B. Blau
- Paul Scherrer Institute, Villigen PSI, Switzerland
| | - M. Daum
- Paul Scherrer Institute, Villigen PSI, Switzerland
| | - N. Hild
- Paul Scherrer Institute, Villigen PSI, Switzerland
| | - K. Kirch
- Paul Scherrer Institute, Villigen PSI, Switzerland
| | | | - D. Ries
- Paul Scherrer Institute, Villigen PSI, Switzerland
| | | | - V. Talanov
- Paul Scherrer Institute, Villigen PSI, Switzerland
| | | | - G. Zsigmond
- Paul Scherrer Institute, Villigen PSI, Switzerland
| |
Collapse
|
3
|
Cucu MG, Streața I, Riza AL, Cimpoeru AL, Șerban-Șoșoi S, Ciocoiu A, Pleșea RM, Popescu EL, Dorobanțu Ș, Anghel A, Stroe AM, Ștefan AN, Cioboată R, Băzăvan I, Ciontea MS, Căpitănescu I, Olteanu M, Nițu M, Burada F, Tătaru T, Netea M, van Crevel R, Olaru M, Mixich F, Ioana M. Polymorphisms in autophagy genes and active pulmonary tuberculosis susceptibility in Romania. REV ROMANA MED LAB 2017. [DOI: 10.1515/rrlm-2017-0002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
Autophagy, a homeostatic process involved in nutrient regeneration and immune responses, may be involved in intracellular killing of M. tuberculosis. Several studies linked variation in autophagy genes with susceptibility to pulmonary tuberculosis, but others did not confirm these findings.
We genotyped single nucleotide polymorphisms (SNPs) in the ATG5 (rs2245214, c.574-12777G>C) and NOD2 (rs2066844, c.2104C>T) genes for 256 pulmonary tuberculosis patients and 330 unrelated healthy controls in Romania. Both SNPs have been reported as relevant for the autophagy process and potentially for susceptibility to active pulmonary tuberculosis.
In our study, the polymorphisms in ATG5 and NOD2 were not associated with tuberculosis. This suggests that the two genetic variants we focused on are not related to the risk for developing active TB in a Romanian population.
Collapse
Affiliation(s)
| | - Ioana Streața
- University of Medicine And Pharmacy Craiova, Dolj County, Romania
| | - Anca Lelia Riza
- University of Medicine And Pharmacy Craiova, Dolj County, Romania
| | | | | | - Adela Ciocoiu
- University of Medicine And Pharmacy Craiova, Dolj County, Romania
| | | | | | | | - Andreea Anghel
- University of Medicine And Pharmacy Craiova, Dolj County, Romania
| | - Aida Maria Stroe
- University of Medicine And Pharmacy Craiova, Dolj County, Romania
| | | | - Ramona Cioboată
- “Victor Babes” Infectious Diseases and Pneumophtisiology Hospital Craiova, Dolj County, Romania
| | - Ileana Băzăvan
- “Victor Babes” Infectious Diseases and Pneumophtisiology Hospital Craiova, Dolj County, Romania
| | | | - Iulia Căpitănescu
- “Tudor Vladimirescu” Pneumophtisiology Hospital Runcu, Gorj County, Romania
| | - Mihai Olteanu
- “Victor Babes” Infectious Diseases and Pneumophtisiology Hospital Craiova, Dolj County, Romania
| | - Mimi Nițu
- “Victor Babes” Infectious Diseases and Pneumophtisiology Hospital Craiova, Dolj County, Romania
| | - Florin Burada
- University of Medicine And Pharmacy Craiova, Dolj County, Romania
| | | | - Mihai Netea
- Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands
| | - Reinout van Crevel
- Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands
| | - Marian Olaru
- “Victor Babes” Infectious Diseases and Pneumophtisiology Hospital Craiova, Dolj County, Romania
| | - Francisc Mixich
- University of Medicine And Pharmacy Craiova, Dolj County, Romania
| | - Mihai Ioana
- University of Medicine And Pharmacy Craiova, Dolj County, Romania
| |
Collapse
|
4
|
Laribi K, Tempescul A, Ghnaya H, Denizon N, Besançon A, Anghel A, Farhi J, Truong C, Lemaire P, Poulain S, Bolle D, Ianotto JC, Baugier de Materre A. The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma. Hematol Oncol 2016; 35:536-541. [PMID: 27443419 DOI: 10.1002/hon.2334] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2016] [Revised: 06/21/2016] [Accepted: 06/29/2016] [Indexed: 12/13/2022]
Abstract
Primary nodal marginal zone lymphoma (NMZL) is a rare disease. There is no current consensus on how to treat it. The bendamustine plus rituximab (BR) regimen is effective for the treatment of follicular and other indolent lymphomas, but its efficacy in NMZL is not known. We analyzed the outcome of 14 patients diagnosed with NMZL (median age 67 years) who were treated with 375 mg/m2 of rituximab on day 1 and 90 mg/m2 of bendamustine on days 1 and 2. The overall and complete response rates were 93% and 71%, respectively. Major toxicity (grade 3/4 neutropenia) occurred in 5% of treatment courses. After a median follow-up of 22 months (range: 18-55), the overall survival and the free survival rates were 100% and 93%, respectively. None of the patients showing a complete or partial response developed secondary myelodysplastic syndrome/acute myeloid leukemia. Bendamustine plus rituximab was found to be an active and well-tolerated regimen leading to the rapid control of disease.
Collapse
Affiliation(s)
- Kamel Laribi
- Department of Hematology, Centre Hospitalier du Mans, Le Mans, France
| | - Adrien Tempescul
- Department of Hematology, Institut de Cancéro-Hématologie, CHRU Brest, Brest, France
| | - Habib Ghnaya
- Department of Hematology, Centre Hospitalier du Mans, Le Mans, France
| | - Nathalie Denizon
- Department of Hematology, Centre Hospitalier du Mans, Le Mans, France
| | - Anne Besançon
- Department of Hematology, Centre Hospitalier du Mans, Le Mans, France
| | - Andreea Anghel
- Department of Hematology, Centre Hospitalier du Mans, Le Mans, France
| | - Jonathan Farhi
- Department of Hematology, Centre Hospitalier du Mans, Le Mans, France
| | - Catherine Truong
- Clinical Research Center, Centre Hospitalier du Mans, Le Mans, France
| | - Pierre Lemaire
- Laboratory of Biology and Hematology, Centre Hospitalier du Mans, Le Mans, France
| | - Stephanie Poulain
- Service d'Hématologie-Immunologie-Cytogénétique, Centre Hospitalier de Valenciennes, Valenciennes, France.,Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, Lille, France.,INSERM UMR 1172, IRCL, Lille, France
| | - Delphine Bolle
- Department of Pharmacy, Centre Hospitalier du Mans, Le Mans, France
| | | | | |
Collapse
|
5
|
Corlan Puşcu D, Ciuluvică RC, Anghel A, Mălăescu GD, Ciursaş AN, Popa GV, Agop Forna D, Busuioc CJ, Siloşi I. Periodontal disease in diabetic patients - clinical and histopathological aspects. Rom J Morphol Embryol 2016; 57:1323-1329. [PMID: 28174799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Periodontal disease is one of the most frequent diseases affecting people all over the world. The relation between periodontal disease and diabetes mellitus raised the interest both of dentists and doctors treating metabolic diseases, as the two conditions influence one another. In our study, we analyzed a number of 75 patients with diabetes mellitus and periodontal disease that presented to the medical consultory for conditions of the dental maxillary system. The clinical study showed that periodontal disease and diabetes may affect young adults as well, still this pathological association more frequently appears after the age of 50. The disease was identified especially in the women living in urban area. The clinical examination of the dental maxillary system identified the presence of gingival ulcerations, dental calculus, gingival bleeding, radicular leftovers with anfractuous margins, fixed prostheses with an inappropriate cervical adjustment. Of the systemic diseases associated to periodontal disease and diabetes mellitus, there was observed that 66.66% of the patients also suffered from cardiovascular diseases (high blood pressure, ischemic cardiopathy, heart failure), and 37.33% suffered from obesity. The histopathological and immunohistochemical tests highlighted the presence of an inflammatory chronic, intense reaction, mainly formed of lymphocytes, plasmocytes, macrophages and granulocytes, heterogeneously disseminated and alteration of the structure of marginal and superficial periodontium. The inflammatory reaction in the patients with periodontal disease and diabetes was more intense than in the patients with periodontal disease without diabetes.
Collapse
Affiliation(s)
- Dorina Corlan Puşcu
- Research Center for Microscopic Morphology and Immunology, University of Medicine and Pharmacy of Craiova, Romania;
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Rusu D, Stratul SI, Sarbu C, Roman A, Anghel A, Didilescu A, Jentsch H. Evaluation of a hydrophobic gel adhering to the gingiva in comparison with a standard water-soluble 1% chlorhexidine gel after scaling and root planing in patients with moderate chronic periodontitis. A randomized clinical trial. Int J Dent Hyg 2015; 15:53-64. [PMID: 26053503 DOI: 10.1111/idh.12155] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/29/2014] [Indexed: 11/29/2022]
Abstract
OBJECTIVES To evaluate the clinical, microbiological and enzymatic activity of a hydrophobic chlorhexidine-based gingiva-adhering gel containing herbal ingredients, compared with a commercially available 1% chlorhexidine water-soluble gel, during non-surgical therapy of moderate chronic periodontitis. METHODS A total of 34 subjects participated in this 6-month blinded randomized parallel controlled trial (ISRCTN35210084). After scaling and root planing (SRP), test group received the gel, by rubbing on the gingiva, once every second day, for 14 days. The control group received the control gel twice daily. Clinical parameters considered were the approximal plaque index, simplified oral hygiene index, modified gingival index, bleeding on probing, probing depth and clinical attachment level (primary outcome), assessed at baseline, 3 and 6 months, together with the frequency of detection of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis (P.g.), Prevotella intermedia, Treponema denticola (T.d.), Tannerella forsythia (T.f.), and activity of neutrophil elastase and myeloperoxidase (secondary outcomes). RESULTS At 3 and 6 months, all clinical parameters improved significantly, without significant intergroup differences, except OHI-S, which improved at 3 months (P < 0.05). Microbiological data resulted in no significant intergroup differences at baseline and 6 months. At 3 months, significant differences for P.g., T.f. and T.d. were noted. A significant reduction of neutrophil elastase after 3 and 6 months was observed (P < 0.005), without significant intergroup differences. For myeloperoxidase, significant reductions were noted in both groups (P < 0.005 and P < 0.05), but no significant intergroup differences. The tested product seemed to have an increased efficacy, due to longer persistence on the gingiva, with reduced application frequency. CONCLUSIONS Both products had a relatively similar influence on the clinical, microbiological and enzymatic outcomes at 3 and 6 months after SRP.
Collapse
Affiliation(s)
- D Rusu
- Department of Periodontology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - S-I Stratul
- Department of Periodontology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - C Sarbu
- Department of Periodontology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - A Roman
- Department of Periodontology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
| | - A Anghel
- Department of Biochemistry, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - A Didilescu
- Department of Embryology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - H Jentsch
- Centre for Periodontology, Department of Conservative Dentistry and Periodontology, University of Leipzig, Leipzig, Germany
| |
Collapse
|
7
|
Licker M, Anghel A, Moldovan R, Hogea E, Muntean D, Horhat F, Seclaman E, Tamas L, Anghel M, Baditoiu L. Genotype-phenotype correlation in multiresistant Escherichia coli and Klebsiella pneumoniae strains isolated in Western Romania. Eur Rev Med Pharmacol Sci 2015; 19:1888-1894. [PMID: 26044236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE Bacterial multidrug-resistance (MDR) to antimicrobials has become an important public health issue all over the world and it involves both hospital and community-acquired strains. MATERIALS AND METHODS A number of 75 Escherichia coli and 77 Klebsiella pneumoniae (K.) strains identified in biological samples collected from community (CA) and hospital-acquired (HA) infections were found to be resistant to the third generation cephalosporins. Of these, 93 MDR strains were subjected to microarray analysis to detect the expression of 31 antimicrobial resistance genes. RESULTS We found that all HA extended-spectrum β-lactamase (ESBL) producing E. coli strains had at least one resistance gene to third generation cephalosporins, while in 54% of all CA strains genetic substrates justifying their antibiotic resistance were identified. Almost 81% of HA-ESBL (Extended-Spectrum β Lactamase) K. pneumoniae strains had at least one resistance gene to third generation cephalosporins, while in only 6% of the CA strains a similar genotype was identified. In the HA group, the blaCTX-M-15 genotype proved to be most frequent in multidrug-resistant E. coli strains and second most frequent (after ampC) in K. pneumoniae, while in the CA group, this genotype was the fourth most frequent in ESBL E. coli (after ampC, sul1, tet(R)). CONCLUSIONS Overall, in 67% of all ESBL producing Enterobacteriaceae strains a genetic substrate justifying the resistance to beta-lactam antibiotics was identified; most of the remaining 33.33% strains were CA with a predominance of K. pneumoniae, in which a different antibiotic resistance genetic substrate (outside the detection limit of the kit used in this study) might have been involved.
Collapse
Affiliation(s)
- M Licker
- "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Cristian D, Poalelungi A, Anghel A, Burcoş T, Grigore R, Berteşteanu S, Richiteanu G, Grama F. Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) - The Importance of Nutritonal Support in Patients with Head and Neck Cancers (HNCs) or Neurogenic Dysphagia (ND). Chirurgia (Bucur) 2015; 110:129-136. [PMID: 26011834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/01/2015] [Indexed: 06/04/2023]
Abstract
BACKGROUND We evaluated the effectiveness and safety of prophylactic PEG performed for the enteral nutrition support during the oncological treatment of patients with HNCs and as a part of the management of neurological patients experiencing neurogenic dysphagia. METHODS In 2013 we followed up on a group of 23 HNC patients subjected to prophylactic PEG. We assessed the duration of the procedure, intraprocedural incidents and their causes, time to tube-refeeding and discharge after intervention, post interventional analgesia, early and late complications,toleration, costs and postoperative course of these patients after radical surgery maintaining PEG in place. In parallel we followed up on a group of 10 neurological patients who have undergone a PEG placement to improve the nutrional status and to prevent recurrent chest infections due to ND related silent aspiration. RESULTS The procedures were performed under sedation with Midazolam and the mean duration was about 7 minutes.Postoperative analgesia was minimal. Refeeding through the tube was initiated 2-4h hours later and the patients were discharged 12-24h after the procedure. Early complications were not observed and later we noted 2 cases of peristomal infections, succesfully managed conservatively. After oncologic surgery we noted 2 (8.69%) pharyngocutaneous fistulas.Conservative care obliterated the fistulas at 6 weeks, maintaining the feeding tube in place. We also compared the results with a group of 27 patients fed through the naso-gastric tube and a group of 20 cases with open gastrotomy-tube prophylactically inserted. The 10 neurological patients had varied conditions but degenerative diseases like motor neuron disease (3 cases" 30%) and multiple sclerosis (2 cases -20%) took the lead we encountered one case of peristomal infection and one case of tube blockage resolved by replacement. We evaluated the nutritional status by controling the weight of these patients before and after PEG placement. A mean weight gain of 3.1 kg(range 1.2 â" 7) was documented. CONCLUSIONS PEG is a simple minimmaly invasive procedure performed safely under sedation. It takes a very short time and is virtually free of major complications. The requirements of analgesics are minimal. The refeeding is started early and the tube is well tolerated by the patient. PEG has an important role in the conservative healing of pharyngocutaneous fistula.PEG is the procedure of choice for the neurological patients.It prevents weight loss and aspiration pneumonia in patients with neurogenic dysphagia with a low rate of complications.
Collapse
|
9
|
Raducu L, Anghel A, Vermesan S, Sinescu RD. Finger enchondroma treated with bone substituents - a case presentation. J Med Life 2014; 7:223-5. [PMID: 25408730 PMCID: PMC4197501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2014] [Accepted: 03/25/2014] [Indexed: 11/13/2022] Open
Abstract
About 90% of the hand bone tumors are enchondromas. Treatment of choice is complete curettage and bone grafting, usually with bone autografts. We present a case of finger enchondroma in a 27-year-old female patient who was treated with curettage and synthetic bone grafting. Clinical, surgical and pathological findings in this case are presented along with a brief discussion of literature.
Collapse
Affiliation(s)
- L Raducu
- Department of Plastic Surgery, "Agrippa Ionescu" Military Emergency Hospital, Bucharest, Romania
| | - A Anghel
- Department of Plastic Surgery and Reconstructive Microsurgery, "Elias" Emergency University Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
| | - S Vermesan
- Department of Orthopedic Surgery, "Agrippa Ionescu" Military Emergency Hospital, Bucharest, Romania
| | - RD Sinescu
- Department of Plastic Surgery and Reconstructive Microsurgery, "Elias" Emergency University Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
| |
Collapse
|
10
|
Chiotan C, Radu L, Serban R, Cornăcel C, Cioboata M, Anghel A. Cytomegalovirus retinitis in HIV/AIDS patients. J Med Life 2014; 7:237-40. [PMID: 25408732 PMCID: PMC4197487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2013] [Accepted: 01/29/2014] [Indexed: 11/02/2022] Open
Abstract
UNLABELLED Human immunodeficiency virus (HIV) has the ability to affect any organ in the body. In 70% of HIV-infected patients ocular manifestations were observed, which in the vast majority reflect the systemic disease and may be the first sign of a disseminated infection. AIM The purpose of this paper is to determine the prevalence and the clinical aspects of cytomegalovirus retinitis in HIV/AIDS (Acquired Immunodeficiency Syndrome) patients. METHOD The study is retrospective, conducted in the Ophthalmology Office of "Matei Bals" Infectious Diseases Hospital in Bucharest during the period August 1, 2007 - August 1, 2013. Each patient was examined thoroughly at the slit lamp biomicroscope by using a lens of 90D and a 20D lens using the indirect microscope after administration of topical mydriatics. RESULTS 131 patients were followed for HIV / AIDS with posterior segment ocular involvement. 36.64% of the 131 patients having affected the posterior segment have been diagnosed with CMV retinitis. CONCLUSIONS Doctors should be aware of the existence of ocular damage in HIV/AIDS and to emphasize the importance of regular ophthalmologic examination of patients with HIV/AIDS.
Collapse
Affiliation(s)
- C Chiotan
- Prof. Dr. Matei Bals" National Institute of Infectious Diseases Bucharest,
Department of HIV / AIDS, Office of Ophthalmology
| | | | - R Serban
- Ophthalmology Emergency Hospital, Bucharest
| | | | - M Cioboata
- Ophthalmology Emergency Hospital, Bucharest
| | | |
Collapse
|
11
|
Sporea I, Badea R, Popescu A, Spârchez Z, Sirli RL, Dănilă M, Săndulescu L, Bota S, Calescu DP, Nedelcu D, Brisc C, Ciobâca L, Gheorghe L, Socaciu M, Martie A, Ioaniţescu S, Tamas A, Streba CT, Iordache M, Simionov I, Jinga M, Anghel A, Cijevschi Prelipcean C, Mihai C, Stanciu SM, Stoicescu D, Dumitru E, Pietrareanu C, Bartos D, Manzat Saplacan R, Pârvulescu I, Vădan R, Smira G, Tuţă L, Săftoiu A. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice. Ultraschall Med 2014; 35:259-66. [PMID: 24563420 DOI: 10.1055/s-0033-1355728] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
PURPOSE To assess the value of contrast-enhanced ultrasound (CEUS) for differentiating malignant from benign focal liver lesions (FLLs) and for diagnosing different FLL types. MATERIAL AND METHODS CEUS performed in 14 Romanian centers was prospectively collected between February 2011 and June 2012. The inclusion criteria were: age > 18 years; patients diagnosed with 1 - 3 de novo FLLs on B-mode ultrasound; reference method (computed tomography (CT), magnetic resonance imaging (MRI) or biopsy) available; patient's informed consent. FLL lesions were characterized during CEUS according to the European Federation of Societies for Ultrasound in Medicine and Biology guidelines. For statistical analysis, indeterminate FLLs at CEUS were rated as false classifications. RESULTS A total number of 536 cases were included in the final analysis, 344 malignant lesions (64.2 %) and 192 benign lesions (35.8 %). The reference method was: CT/MRI - 379 cases (70.7 %), pathological exam - 150 cases (27.9 %) and aspiration of liver abscesses - 7 cases (1.4 %). CEUS was conclusive in 89.3 % and inconclusive in 10.7 % of cases. To differentiate between malignant and benign FLLs, CEUS had 85.7 % sensitivity, 85.9 % specificity, 91.6 % positive predictive value, 77.1 % negative predictive value and 85.8 % accuracy. The CEUS accuracy for differentiation between malignant and benign liver lesions was similar in tumors with diameter ≤ 2 cm and those with diameter > 2 cm. CONCLUSION CEUS represents a useful method in clinical practice for differentiating between malignant and benign FLLs detected on standard ultrasonography, and the results of this study are in concordance with previous multicenter studies: DEGUM (Germany) and STIC (France).
Collapse
Affiliation(s)
- I Sporea
- Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy "Victor Babeş" Timişoara, Romania
| | - R Badea
- Regional Institute of Gastroenterology and Hepatology "Prof. Dr. Octavian Fodor", University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Romania
| | - A Popescu
- Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy "Victor Babeş" Timişoara, Romania
| | - Z Spârchez
- Regional Institute of Gastroenterology and Hepatology "Prof. Dr. Octavian Fodor", University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Romania
| | - R L Sirli
- Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy "Victor Babeş" Timişoara, Romania
| | - M Dănilă
- Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy "Victor Babeş" Timişoara, Romania
| | - L Săndulescu
- Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy, Craiova, Romania
| | - S Bota
- Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy "Victor Babeş" Timişoara, Romania
| | - D P Calescu
- Department of Gastroenterology, Emergency Hospital Floreasca, Bucharest, Romania
| | - D Nedelcu
- Delta Promedical Hospital, Bucharest, Romania
| | - C Brisc
- Department of Gastroenterology, University of Oradea, Romania
| | - L Ciobâca
- 1st Medical Department, Central Military Emergency University Hospital "Dr. Carol Davila", Bucharest, Romania
| | - L Gheorghe
- IIIrd Department of Gastroenterology and Hepatology, Clinical Institute Fundeni, Bucharest, Romania
| | - M Socaciu
- Regional Institute of Gastroenterology and Hepatology "Prof. Dr. Octavian Fodor", University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Romania
| | - A Martie
- Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy "Victor Babeş" Timişoara, Romania
| | - S Ioaniţescu
- Center of Internal Medicine, Fundeni Clinical Institute, Bucharest, Romania
| | - A Tamas
- Department of Anatomy and Embriology, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Romania
| | - C T Streba
- Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy, Craiova, Romania
| | - M Iordache
- 1st Medical Department, Central Military Emergency University Hospital "Dr. Carol Davila", Bucharest, Romania
| | - I Simionov
- IIIrd Department of Gastroenterology and Hepatology, Clinical Institute Fundeni, Bucharest, Romania
| | - M Jinga
- 1st Medical Department, Central Military Emergency University Hospital "Dr. Carol Davila", Bucharest, Romania
| | - A Anghel
- 1st Medical Department, Central Military Emergency University Hospital "Dr. Carol Davila", Bucharest, Romania
| | - C Cijevschi Prelipcean
- Institute of Gastroenterology and Hepatology, "Grigore T. Popa" University of Medicine and Pharmacy Iaşi, Romania
| | - C Mihai
- Institute of Gastroenterology and Hepatology, "Grigore T. Popa" University of Medicine and Pharmacy Iaşi, Romania
| | - S M Stanciu
- 1st Medical Department, Central Military Emergency University Hospital "Dr. Carol Davila", Bucharest, Romania
| | - D Stoicescu
- 1st Medical Department, Central Military Emergency University Hospital "Dr. Carol Davila", Bucharest, Romania
| | - E Dumitru
- Department of Gastroenterology, University of Constanta, Romania
| | - C Pietrareanu
- IIIrd Department of Gastroenterology and Hepatology, Clinical Institute Fundeni, Bucharest, Romania
| | - D Bartos
- Department of Internal Medicine and Gastroenterology, Emergency Hospital Floreasca, Bucharest, Romania
| | - R Manzat Saplacan
- Ist, Medical Clinic, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca, Cluj Napoca, Romania
| | - I Pârvulescu
- IIIrd Department of Gastroenterology and Hepatology, Clinical Institute Fundeni, Bucharest, Romania
| | - R Vădan
- IIIrd Department of Gastroenterology and Hepatology, Clinical Institute Fundeni, Bucharest, Romania
| | - G Smira
- IIIrd Department of Gastroenterology and Hepatology, Clinical Institute Fundeni, Bucharest, Romania
| | - L Tuţă
- Department of Gastroenterology, University of Constanta, Romania
| | - A Săftoiu
- Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy, Craiova, Romania
| |
Collapse
|
12
|
Calvi M, Schmidt T, Anghel A, Cervellino A, Leake SJ, Willmott PR, Tanaka T. Commissioning results of the U14 cryogenic undulator at SLS. ACTA ACUST UNITED AC 2013. [DOI: 10.1088/1742-6596/425/3/032017] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
13
|
Anghel A, Ardana-Lamas F, Le Pimpec F, Hauri CP. Large charge extraction from metallic multifilamentary Nb3Sn photocathode. Phys Rev Lett 2012; 108:194801. [PMID: 23003048 DOI: 10.1103/physrevlett.108.194801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/07/2011] [Indexed: 06/01/2023]
Abstract
The current density limit for photoemission from metals was measured in an rf photogun to be below 10(9) A/m2. We have achieved 1.6×10(11) A/m2 by photofield emission from a new type of photocathode made from a metallic-composite, multifilamentary Nb3Sn wire driven by a 266 nm picosecond laser pulse and a 2 ns, 50 kV accelerating voltage. This cathode has a micrometer arrayed structure with tens of thousands of Nb/Nb3Sn filaments embedded in a bronze matrix. Our measurements revealed the existence of a new electron emission regime at high laser fluence (100 mJ/cm2). We have extracted stably, and without any surface ablation, up to 4800 pC of charge. This corresponds to 0.9% quantum efficiency, 100 times larger than what is measured from conventional metallic photocathodes. The unexpected large and stable charge extraction cannot be explained by the 3-step model. Thanks to the small emitting area, the measured emittance (0.6 mm·mrad) is low in spite of the high current density and space charge effects. This cathode will be of benefit for many applications based on short and bright electron bunches.
Collapse
Affiliation(s)
- A Anghel
- Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland.
| | | | | | | |
Collapse
|
14
|
Didilescu AC, Rusu D, Anghel A, Nica L, Iliescu A, Greabu M, Bancescu G, Stratul SI. Investigation of six selected bacterial species in endo-periodontal lesions. Int Endod J 2011; 45:282-93. [DOI: 10.1111/j.1365-2591.2011.01974.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
15
|
Wang Y, Nakagawa Y, Liu L, Wang W, Ren X, Anghel A, Lutfy K, Friedman TC, Liu Y. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes. Diabetologia 2011; 54:440-50. [PMID: 21052977 PMCID: PMC3795617 DOI: 10.1007/s00125-010-1956-9] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2010] [Accepted: 09/28/2010] [Indexed: 01/15/2023]
Abstract
AIMS/HYPOTHESIS Tissue-specific amplification of glucocorticoid action through 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) affects the development of the metabolic syndrome. Hexose-6-phosphate dehydrogenase (H6PDH) mediates intracellular NADPH availability for 11β-HSD1 and depends on the glucose-6-phosphate transporter (G6PT). Little is known about the tissue-specific alterations of H6PDH and G6PT and their contributions to local glucocorticoid action in db/db mice. METHODS We characterised the role of H6PDH and G6PT in pre-receptor metabolism of glucocorticoids by examining the production of the hepatic 11β-HSD1-H6PDH-G6PT system in db/db mice. RESULTS We observed that increased production of hepatic H6PDH in db/db mice was paralleled by upregulation of hepatic G6PT production and responded to elevated circulating levels of corticosterone. Treatment of db/db mice with the glucocorticoid antagonist RU486 markedly reduced production of both H6PDH and 11β-HSD1 and improved hyperglycaemia and insulin resistance. The reduction of H6PDH and 11β-HSD1 production by RU486 was accompanied by RU486-induced suppression of hepatic G6pt (also known as Slc37a4) mRNA. Incubation of mouse primary hepatocytes with corticosterone enhanced G6PT and H6PDH production with corresponding activation of 11β-HSD1 and PEPCK: effects that were blocked by RU486. Knockdown of H6pd by small interfering RNA showed effects comparable with those of RU486 for attenuating the corticosterone-induced H6PDH production and 11ß-HSD1 reductase activity in these intact cells. Addition of the G6PT inhibitor chlorogenic acid to primary hepatocytes suppressed H6PDH production. CONCLUSIONS/INTERPRETATION These findings suggest that increased hepatic H6PDH and G6PT production contribute to 11β-HSD1 upregulation of local glucocorticoid action that may be related to the development of type 2 diabetes.
Collapse
Affiliation(s)
- Y. Wang
- Division of Endocrinology, Metabolism & Molecular Medicine, Charles Drew University of Medicine & Sciences, UCLA School of Medicine, 1731 E. 120th St, Los Angeles, CA 90059, USA
| | - Y. Nakagawa
- Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan
| | - L. Liu
- Department of Endocrinology & Metabolism, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai Diabetes Institute, Shanghai, People’s Republic of China
| | - W. Wang
- Division of Endocrinology, Metabolism & Molecular Medicine, Charles Drew University of Medicine & Sciences, UCLA School of Medicine, 1731 E. 120th St, Los Angeles, CA 90059, USA
| | - X. Ren
- Division of Endocrinology, Metabolism & Molecular Medicine, Charles Drew University of Medicine & Sciences, UCLA School of Medicine, 1731 E. 120th St, Los Angeles, CA 90059, USA
| | - A. Anghel
- Division of Endocrinology, Metabolism & Molecular Medicine, Charles Drew University of Medicine & Sciences, UCLA School of Medicine, 1731 E. 120th St, Los Angeles, CA 90059, USA
| | - K. Lutfy
- Division of Endocrinology, Metabolism & Molecular Medicine, Charles Drew University of Medicine & Sciences, UCLA School of Medicine, 1731 E. 120th St, Los Angeles, CA 90059, USA
| | - T. C. Friedman
- Division of Endocrinology, Metabolism & Molecular Medicine, Charles Drew University of Medicine & Sciences, UCLA School of Medicine, 1731 E. 120th St, Los Angeles, CA 90059, USA
| | - Y. Liu
- Division of Endocrinology, Metabolism & Molecular Medicine, Charles Drew University of Medicine & Sciences, UCLA School of Medicine, 1731 E. 120th St, Los Angeles, CA 90059, USA
| |
Collapse
|
16
|
Nariţa D, Seclaman E, Ursoniu S, Ilina R, Cireap N, Anghel A. Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls. Rom J Morphol Embryol 2011; 52:1261-1267. [PMID: 22203932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
A growing body of laboratory research has shown that pro-inflammatory cytokines can facilitate tumor growth and metastasis. Our goal was to quantify the expression of CCL18 and IL-6 in patients with breast cancer compared with benign breast tumors patients and healthy women, in order to evaluate if these cytokines could serve for breast cancer diagnosis and evaluation. We also correlated the cytokines level of expression with some clinical and pathological characteristics known as prognostic markers for breast cancer. Plasma samples were obtained before treatment from 58 breast cancers, 41 benign breast tumors and 30 healthy women. The quantitative dosage was performed using ELISA. Wilcoxon test was used to compare groups. IL-6 and CCL18 were dramatically upregulated in breast cancers in comparison with healthy controls, but in comparison with benign tumors only CCL18÷PARC was overexpressed at borderline significance in cancers (p=0.05). The plasma from benign breast tumor patients exhibited also significant higher levels of the two cytokines than normal controls. The cytokines profile was not linked to patient age, tumor size, histopathological type, lymph node status or histological grade. IL-6 was significantly upregulated in ER-positive and metastasized cancers. CCL18÷PARC presented a significantly higher expression in advanced stage and highly proliferative carcinomas. In summary, IL-6 and CCL18 could clearly distinguish between women with breast cancers and healthy controls. High expression of IL-6 seems to confer a poor prognosis for ER-positive cancers. CCL18 was associated with worse prognosis parameters like high Ki67.
Collapse
Affiliation(s)
- Diana Nariţa
- Department of Biochemistry, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | | | | | |
Collapse
|
17
|
Currie P, Anghel A, Weinberg Z, Jacoby S, Sutherland M. Urocortin microinjection into the lateral septal area alters appetite and energy substrate utilization. Appetite 2010. [DOI: 10.1016/j.appet.2010.04.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
18
|
Anghel A, Jamieson CAM, Ren X, Young J, Porche R, Ozigbo E, Ghods DE, Lee ML, Liu Y, Lutfy K, Friedman TC. Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake. Neuroscience 2010; 167:554-66. [PMID: 20144693 DOI: 10.1016/j.neuroscience.2010.01.043] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2009] [Revised: 01/07/2010] [Accepted: 01/21/2010] [Indexed: 10/19/2022]
Abstract
Addictive drugs including opioids activate signal transduction pathways that regulate gene expression in the brain. However, changes in CNS gene expression following morphine exposure are poorly understood. We determined changes in gene expression following short- and long-term morphine treatment in the hypothalamus and pituitary using genome-wide DNA microarray analysis and confirmed those alterations in gene expression by real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis. In the hypothalamus, short-term morphine administration up-regulated (at least twofold) 39 genes and down-regulated six genes. Long-term morphine treatment up-regulated 35 genes and down-regulated 51 genes. In the pituitary, short-term morphine administration up-regulated 110 genes and down-regulated 29 genes. Long-term morphine treatment up-regulated 85 genes and down-regulated 37 pituitary genes. Microarray analysis uncovered several genes involved in food intake (neuropeptide Y, agouti-related protein, and cocaine and amphetamine-regulated transcript) whose expression was strongly altered by morphine exposure in either the hypothalamus or pituitary. Subsequent RT-PCR analysis confirmed similar regulation in expression of these genes in the hypothalamus and pituitary. Finally, we found functional correlation between morphine-induced alterations in food intake and regulation of genes involved in this process. Changes in genes related to food intake may uncover new pathways related to some of the physiological effects of opioids.
Collapse
Affiliation(s)
- A Anghel
- Division of Endocrinology, Department of Medicine, Charles Drew University of Medicine and Sciences-UCLA School of Medicine, Los Angeles, CA 90059, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Narita D, Anghel A, Cimpean A, Izvernariu D, Cireap N, Ilina R, Ursoniu S. Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer. Neoplasma 2010; 57:198-206. [DOI: 10.4149/neo_2010_03_198] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
20
|
Nariţa D, Anghel A, Seclaman E, Ilina R, Cireap N, Ursoniu S. Molecular profiling of ADAM12 gene in breast cancers. Rom J Morphol Embryol 2010; 51:669-676. [PMID: 21103624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
ADAMs (a disintegrin and metalloproteinase) family have been associated with the process of proteolytic "shedding" of membrane-associated proteins ectodomain and hence the rapid modulation of key cell signaling pathways in tissues microenvironment. A variety of cytokines, chemokines and growth factors which are initially produced as transmembrane proforms are activated by these sheddase activities. ADAM12 is highly expressed in rapidly growing tissues such as placenta and malignant tumors and it was found as one of the Candidate Cancer Genes in a comprehensive mutational analysis of human breast cancers. Our aim was to determine the gene expression profile of ADAM12 in breast cancers in comparison with normal breast and to correlate their level of expression with the clinical and pathological characteristics of breast cancers. Gene expression of ADAM12 spliced variants (12L and 12S) was evaluated using quantitative reverse-transcription PCR in samples obtained by laser capture microdissection from 38 patients with breast cancers and compared with adjacent healthy breast tissues. Both ADAM12L and 12S expression were significantly up-regulated in breast cancers, while in the normal breast, we found a very low expression. ADAM12L expression was significantly correlated with the histopathological types and, although not statistically significant, ADAM12 both variants were up-regulated in high-grade, highly-proliferative and HER2÷neu positive tumors. From these preliminary results, we found that ADAM12 could be an interesting marker and eventually a therapeutic target for breast cancer.
Collapse
Affiliation(s)
- Diana Nariţa
- Department of Biochemistry, Victor Babes, University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | | | | | |
Collapse
|
21
|
Anghel A, Raica M, Narita D, Seclaman E, Nicola T, Ursoniu S, Anghel M, Popovici E. Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer. Neoplasma 2010; 57:306-15. [DOI: 10.4149/neo_2010_04_306] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
22
|
Tamas L, Popa Z, Pop L, Popa I, Anghel A, Popa Z, Samoila C, Ciuca I. The spectrum of CFTR mutations in populations from Romania. J Cyst Fibros 2009. [DOI: 10.1016/s1569-1993(09)60035-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
23
|
Espinosa VP, Liu Y, Ferrini M, Anghel A, Nie Y, Tripathi PV, Porche R, Jansen E, Stuart RC, Nillni EA, Lutfy K, Friedman TC. Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the "switch" to opiate addiction. Neuroscience 2008; 156:788-99. [PMID: 18771713 DOI: 10.1016/j.neuroscience.2008.07.063] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2008] [Revised: 07/21/2008] [Accepted: 07/22/2008] [Indexed: 10/21/2022]
Abstract
Drug addiction is a state of altered brain reward and self-regulation mediated by both neurotransmitter and hormonal systems. Although an organism's internal system attempts to maintain homeostasis when challenged by exogenous opiates and other drugs of abuse, it eventually fails, resulting in the transition from drug use to drug abuse. We propose that the attempted maintenance of hormonal homeostasis is achieved, in part, through alterations in levels of processing enzymes that control the ratio of active hormone to pro-hormone. Two pro-hormone convertases, PC1/3 and PC2 are believed to be responsible for the activation of many neurohormones and expression of these enzymes is dependent on the presence of a cyclic-AMP response element (CRE) in their promoters. Therefore, we studied the effects of short-term (24-h) and long-term (7-day) morphine treatment on the expression of hypothalamic PC1/3 and PC2 and levels of phosphorylated cyclic-AMP-response element binding protein (P-CREB). While short-term morphine exposure down-regulated, long-term morphine exposure up-regulated P-CREB, PC1/3 and PC2 protein levels in the rat hypothalamus as determined by Western blot analysis. Quantitative immunofluorescence studies confirmed these regulatory actions of morphine in the paraventricular and dorsomedial nucleus of the hypothalamus. Specific radioimmunoassays demonstrated that the increase in PC1/3 and PC2 levels following long-term morphine led to increased TRH biosynthesis as evidence by increased TRH/5.4 kDa C-terminal proTRH-derived peptide ratios in the median eminence. Promoter activity experiments in rat somatomammotrope GH3 cells containing the mu-opioid receptor demonstrated that the CRE(s) in the promoter of PC1/3 and PC2 is required for morphine-induced regulation of PC1/3 and PC2. Our data suggest that the regulation of the prohormone processing system by morphine may lead to alterations in the levels of multiple bioactive hormones and may be a compensatory mechanism whereby the organism tries to restore its homeostatic hormonal milieu. The down-regulation of PC1/3, PC2 and P-CREB by short-term morphine and up-regulation by long-term morphine treatment may be a signal mediating the switch from drug use to drug abuse.
Collapse
Affiliation(s)
- V Paez Espinosa
- Division of Endocrinology, Department of Medicine, The Charles Drew University of Medicine & Sciences-UCLA School of Medicine, 1731 East 120th Street, Los Angeles, CA 90059, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Wainberg ZA, Dering J, Ginther C, Anghel A, Kalous O, Desai A, Hecht JR, Clark E, Slamon D, Finn RS. Identification of predictive markers of response in colorectal cancer following treatment with dasatinib, an orally active tyrosine kinase inhibitor of ABL and SRC. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.14688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
25
|
Mustata I, Anghel A, Lungu CP, Pompilian O, Kuncser V, Schinteie G. Tunneling magneto-resistance granular thin films deposited by thermo-ionic vacuum arc technique. ACTA ACUST UNITED AC 2008. [DOI: 10.1088/1742-6596/100/8/082026] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
26
|
Flangea C, Potencz E, Mihăescu R, Gîju S, Anghel A. Bcl-2 expression in Hodgkin's lymphoma progression. Rom J Morphol Embryol 2008; 49:357-363. [PMID: 18758641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
INTRODUCTION Hodgkin's lymphoma study by immunohistochemical expression of Bcl-2 in Hodgkin and Reed-Sternberg cells can precise these cases evolutive way. MATERIAL AND METHODS Sixty-three cases of classical Hodgkin's disease, hospitalized into the Hematology Department of the County Hospital No. 1 Timisoara, were studied. Histopathological diagnostic was performed using common staining methods, and for revealing the tumoral developments immunohistochemical staining was performed Bcl-2. RESULTS AND DISCUSSION In our study, the results were noticed a direct relation between the rise of tumoral proliferation index expressions of Bcl-2 and progression of the disease (p < or = 0.001). For I and II stages Bcl-2 expression does not overcome (-/+) category while the III and IV stages, all the cases are situated in (+/-) and (+) categories. No connection we can be noticed between the histological type and Bcl-2 expression although the classic Hodgkin's lymphoma with lymphocyte depletion is considered the most aggressive histological type (p < or = 1). In our study, we found this correlation very important because the main cause of relapses is inadequate staging. In some cases, this staging is difficult; some little lymph nodes could be overlooked because they can be placed in less accessible areas and cannot be evidenced by the most imagistic methods. CONCLUSIONS All the cases were Bcl-2 expression higher than (+/-) and are staged as I and II stages should be reinvestigated and restaged. This immunohistochemical reaction, although less used in Romania, is very accurate. That is very important because the therapeutically attitude is different in advances stages compared to earlier stages.
Collapse
Affiliation(s)
- Corina Flangea
- Biochemistry Department, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | | | |
Collapse
|
27
|
Nariţa D, Anghel A, Motoc M. Prostate-specific antigen may serve as a pathological predictor in breast cancer. Rom J Morphol Embryol 2008; 49:173-180. [PMID: 18516323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
PSA (prostate-specific antigen), a serine protease with chymotrypsin-like activity is the most useful tumor marker for prostate cancer screening, diagnosis, prognosis and monitoring. The identification of PSA in normal and tumoral mammary gland was regarded as a curiosity, but the confirmation of PSA expression in the mammary gland by others teams of researchers and the identification of specific mRNA in tumors with PSA immunoexpression initiated new perspectives for studies. The aim of this study was to examine the prevalence of PSA in breast cancers and to evaluate the correlations between PSA expression and some clinicopathological markers. We analyzed the expression of PSA in series of consecutive breast carcinomas by immunohistochemistry and correlated the PSA expression with the histological type and grade, nodal and metastasis status, estrogen receptor (ER), progesterone receptor (PR), androgen receptor (AR) and HER2/neu expression. PSA expression was observed in 44.5% of breast cancers, particularly in lobular types of carcinoma (p<0.0001). In univariate analysis, the expression of PSA was statistically correlated with AR (p<0.0001), PR (p=0.01) and inversely correlated with HER2/neu overexpression (p=0.008) and G3 (p=0.02). PSA did not significantly correlate with ER expression, lymph node and metastasis status. In multivariate analysis, PR was a moderate predictor (p=0.024) but the lobular type (p=0.000), AR (p=0.000), HER2/neu (p=0.002) and G3 (p=0.008) were strong predictors for PSA immunoexpression.
Collapse
MESH Headings
- Biomarkers, Tumor/metabolism
- Breast Neoplasms/diagnosis
- Breast Neoplasms/metabolism
- Breast Neoplasms/pathology
- Carcinoma, Ductal, Breast/diagnosis
- Carcinoma, Ductal, Breast/metabolism
- Carcinoma, Ductal, Breast/pathology
- Female
- Humans
- Neoplasm Staging
- Prognosis
- Prostate-Specific Antigen/metabolism
- Receptor, ErbB-2/metabolism
- Receptors, Estrogen/metabolism
- Receptors, Progesterone/metabolism
Collapse
Affiliation(s)
- Diana Nariţa
- Department of Biochemistry, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | |
Collapse
|
28
|
Licker M, Anghel A, Tutelcă A, Orb C, Dragomirescu L, Bădiţoiu L, Văduva DB, Crăciunescu M, Muntean D, Hogea E, Moldovan R. [Considerations regarding the nosocomial potential of surgical wards]. Bacteriol Virusol Parazitol Epidemiol 2007; 52:119-123. [PMID: 19326724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
PURPOSES The aim of our study was to determine the prevalence of multiresistant germs with nosocomial potential and their main resistance phenotype and genotype patterns in surgical departments. METHODS Identification of germs was performed by the API system (BioMerieux France) and susceptibility tests by disk-diffusion tests, (CLSI standards) with automatic reading methods (Osiris-Bio Rad Laboratories). ESBL producing E. coli and Klebsiella pneumoniae strains have been also genotyped. RESULTS From 190 samples (urines, wound secretions, blood, etc.); we isolated 106 microbial strains with nosocomial potential. 56 (52.83%) from these strains were represented by enterobacteria, 26 (24.52%) by Gram negative non-fermentative rods, and 24 (22.64%) by Gram positive cocci. CONCLUSIONS We noticed a high prevalence of multidrug resistant germs (ESBL, MRSA, etc). The majority of them were involved in nosocomial surgical site and urinary tract infections.
Collapse
Affiliation(s)
- Monica Licker
- UMF Victor Babe Timişoara, Disciplina de Microbiologie
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Tamas L, Popa I, Pop L, Ciuca Popa I, Popa Z, Anghel A, Motoc M. 5 CFTR mutations detection in patients with cystic fibrosis from Romania using Elucigene CF29 kit. J Cyst Fibros 2007. [DOI: 10.1016/s1569-1993(07)60006-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
Raica M, Cimpean AM, Anghel A. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma. Neoplasma 2007; 54:278-84. [PMID: 17822316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
Abstract
The aim of present study was to investigate the relationship between the immunohistochemical expression of vascular endothelial growth factor (VEGF) and microvessel density (MVD) assessed by CD31 and endoglin (CD105) in renal cell carcinoma (RCC). Specimens from 45 cases of RCC. were formalin-fixed, paraffin embedded, and sections were stained with H&E. Additional sections from each case were stained for VEGF, CD31, CD105, and alpha smooth muscle cell actin (SMA). VEGF immunohistochemical expression was estimated as negative (0), weak positive (+1), moderate positive (+2), and intense positive (+3). Microvessel density (MVD) was estimated on 5 hot spots (x400) from each case, and the arithmetic media was the final result. MVD was separately calculated on slides stained with CD31 and CD105. The rate between mature and immature blood vessels was calculated on slides stained with CD31/CD105/SMA. Statistic analysis was performed with SPSS10.0. The immunoreaction for VEGF was positive in epithelial cells of the renal tubules, and occasionally, in endothelial cells. In RCC, tumor cells were positive in 34 from 45 cases (75.5%). 11 cases were negative, 14 were slightly positive (+1), 13 moderate (+2), and 7 intense (+3). No relationship was found between the expression of VEGF and pathological form and nuclear grade, excepting for the chromophilic variant (3 cases, all positive). CD31 was positive in all cases, and CD105 in 39 cases. The mean values of MVD on slides stained for CD31 and CD105 were: 31.68 (range 9.8-60.2)/20.66 (range 4.2-52.8). The rate CD31/SMA positive blood vessels was 1/0.62. VEGF was expressed in 75.5% of 45 cases with RCC, and the mean value of MVD CD31/CD105 was 31.68/20.66. The immunohistochemical expression of VEGF does not correlate with MVD performed on slides stained for both CD31 and endoglin. The majority of blood vessels in the tumor area are of mature type, with perivascular cells positive for SMA.
Collapse
MESH Headings
- Actins/metabolism
- Aged
- Antigens, CD/metabolism
- Biomarkers, Tumor/metabolism
- Carcinoma, Papillary/blood supply
- Carcinoma, Papillary/metabolism
- Carcinoma, Papillary/pathology
- Carcinoma, Renal Cell/blood supply
- Carcinoma, Renal Cell/metabolism
- Carcinoma, Renal Cell/pathology
- Endoglin
- Humans
- Immunoenzyme Techniques
- Kidney Neoplasms/blood supply
- Kidney Neoplasms/metabolism
- Kidney Neoplasms/pathology
- Microcirculation
- Middle Aged
- Muscle, Smooth/metabolism
- Neovascularization, Pathologic/metabolism
- Neovascularization, Pathologic/pathology
- Platelet Endothelial Cell Adhesion Molecule-1/metabolism
- Prognosis
- Receptors, Cell Surface/metabolism
- Vascular Endothelial Growth Factor A/metabolism
Collapse
Affiliation(s)
- M Raica
- Department of Histology & Cytology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | |
Collapse
|
31
|
Anghel A, Lungu CP, Mustata I, Zaroschi V, Lungu AM, Barbu I, Badulescu M, Pompilian O, Schinteie G, Predoi D, Kunkser V, Filoti G, Apetroaei N. Giant magnetoresistive coatings using thermionic vacuum arc technology. ACTA ACUST UNITED AC 2006. [DOI: 10.1007/s10582-006-0173-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
32
|
Narita D, Cimpean AM, Anghel A, Raica M. Prostate-specific antigen value as a marker in breast cancer. Neoplasma 2006; 53:161-7. [PMID: 16575473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
The immunoexpression of prostate-specific antigen in breast cancers has been well established, but the role of this extra-prostate PSA appears to be a complex, poorly understood and of doubtful prognostic value. In this context, our aim was to evaluate PSA in breast carcinomas and to compare the results with several established prognostic markers of breast cancer: estrogen and progesterone receptors status, HER2/neu status, histological type of tumor, grade of differentiation, stage, tumor size, nodal and menopausal status. We have immunohistochemically assessed 53 breast carcinomas for PSA, ER, PR and oncoprotein HER2/neu status. The relationship between the clinical and histopathological markers was analyzed by chi-square test. In the present study PSA was expressed in 60.3% of cases, and we have found a significant correlation with the histological type and HER2/neu negative status in premenopausal women. No statistically significant difference was found between PSA positivity and menopausal status of the patients, nodal status, estrogen and progesterone receptors, HER2/neu status in postmenopausal patients, tumor size or histological grade. We conclude that in our study PSA can not be considered as a valuable independent prognostic factor in breast carcinoma. As long as the majorities of PSA positive carcinomas were small in size, early stage, better and moderately differentiated, HER2/neu negative and 70% of ER/PR positive carcinomas expressed PSA, it might be useful as a marker for a subset of breast cancers with better prognosis, which could respond to endocrine therapy, in correlation with other prognostic markers.
Collapse
Affiliation(s)
- D Narita
- Department of Biochemistry, "Victor Babes" University of Medicine and Pharmacy, Timisoara 300041, Romania.
| | | | | | | |
Collapse
|
33
|
Flangea C, Potencz E, Mihăescu R, Anghel A, Gîju S, Motoc M, Dogaru C. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging. Rom J Morphol Embryol 2006; 47:113-7. [PMID: 17106517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
INTRODUCTION The presence of Reed-Sternberg malignant cells is absolutely necessary for Hodgkin's lymphoma diagnostic, but it is not always sufficient because can be observed Reed-Sternberg-like cells in other malignant and benign diseases, too. The CD30 expression at Hodgkin and Reed-Sternberg level can give us supplementary information in differential diagnostic and can be used as progressive disease factor. MATERIAL AND METHODS Our study was composed from 63 cases histopathological diagnosed with Hodgkin's lymphoma and hospitalized in Hematology Department of County Hospital Timişoara. CD30 expression was immunohistochemical semi-quantitative evaluated using clone BerH2 as primary antibody and APAAP-New Fuchsin as visualization system. RESULTS AND DISCUSSIONS The increasing of CD30 expression occurs in the same time with advanced stages and the disease progression (p =0.001). For I and II stages CD30 expression does not overcome (-/+) category while the III and IV stages, all the cases are situated in (+/-) and (+) categories. No connection can be noticed between histological type and CD30 expression (p < or = 1). We consider that using this staining, although less used in Romania, must be done in all Hodgkin's lymphoma and Hodgkin's lymphoma-like cases. We say that because the main cause of relapses is represented by inadequate clinical staging and diagnostic. CONCLUSIONS In our study, the increasing of CD30 expression is associated with advanced disease stage. We recommend reinvestigating and restaging all cases that was included into an incipient stages and they have a CD30 expression situated in (+/-) and (+) intervals because some lymph nodes could be overlooked.
Collapse
Affiliation(s)
- Corina Flangea
- Department of Biochemistry, "Victor Babeş" University of Medicine and Pharmacy Timişoara, Timişoara.
| | | | | | | | | | | | | |
Collapse
|
34
|
Samoila C, Otiman G, Carter A, Feuters S, Anghel A. Tu-P10:491 THR40Ala and ARG213Gly polymorphisms of extracellular superoxide dismutase EC-SOD gene in the caucasian population from Western Romania. ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)81192-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
35
|
Bart JM, Morariu S, Knapp J, Ilie MS, Pitulescu M, Anghel A, Cosoroaba I, Piarroux R. Genetic typing of Echinococcus granulosus in Romania. Parasitol Res 2005; 98:130-7. [PMID: 16328370 DOI: 10.1007/s00436-005-0015-9] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2005] [Accepted: 09/02/2005] [Indexed: 11/24/2022]
Abstract
In Romania, cystic echinococcosis is endemic and affects, besides humans, various animal species including sheep, cattle, and swine. As yet, no molecular-genetic typing has been carried out to clearly identify the putative strains being transmitted there. Parasite samples (protoscoleces or germinal layers) were collected from infected intermediate hosts and subsequently analyzed by comparing the PCR-amplified DNA sequences of three targets: one nuclear (BG1/3) and two mitochondrial (cox1 and nadI). Three strains were identified with the mitochondrial sequences: (i) the common sheep strain (G1) which circulates between sheep and cattle and is infective for humans, (ii) the Tasmanian sheep strain (G2) infecting sheep and cattle, and (iii) the pig strain (G7) predominantly found in swine. To our knowledge, this is the first report which demonstrates the occurrence of the Tasmanian sheep strain in cattle and the sympatric occurrence of these three strains (G1, G2, and G7) in Europe.
Collapse
Affiliation(s)
- J M Bart
- SERF Team (Equipe Santé Environment Rural Franche-Comté), Parasitology Department, College of Medicine of Besançon, 19 rue Ambroise Paré, 25000 Besançon, France.
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Wesche R, Anghel A, Bruzzone P, Gislon P, Muzzi L. Analyses and implications of V–I characteristic of PF insert conductor sample. Fusion Engineering and Design 2005. [DOI: 10.1016/j.fusengdes.2005.06.158] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
37
|
Nariţa D, Raica M, Anghel A, Suciu C, Cîmpean A. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast conditions. Rom J Morphol Embryol 2005; 46:41-5. [PMID: 16286983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
We studied 24 selected breast tumors and 3 lymph nodes metastasis from patients with breast carcinoma. The biopsies were formalin-fixed, paraffin-embedded and sections were stained with haematoxylin-eosin. Additional sections from each case were immunostained for prostate specific antigen (PSA), using the EnVision technique. PSA was detected in 7% of normal breast tissues, in 54.5% of benign tumors and 46.5% of malignant tumors. The lesions with apocrine metaplasia were intense and constantly positive, the cystic dilated ducts and the areas with mastopathy were negative. Intense staining for PSA has been found in well-differentiated tumors, while the undifferentiated tumors were usually PSA-negative. The PSA-positivity in 2 of the 3 lymph nodes metastasis indicates that PSA immunoreactivity alone is not an individual prognostic indicator, but it correlates with the hormonal status of the female body. We discuss the results in terms of clinical implications of PSA immunoreactivity detection in mammary gland and other extra-prostatic sources.
Collapse
Affiliation(s)
- Diana Nariţa
- Department of Biochemistry, "Victor Babes" University of Medicine and Pharmacy, Timişoara.
| | | | | | | | | |
Collapse
|
38
|
Anghel A, Marian C, Pitulescu M, Daba A, Sirbu IO, Rusu V, Budowle B. Population genetic study of eight short tandem repeat loci CSF1PO, TPOX, TH01, F13A01, FESFPS, vWA, F13B and LPL in the Western Romanian population. Forensic Sci Int 2003; 131:218-9. [PMID: 12590063 DOI: 10.1016/s0379-0738(02)00435-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Allele frequencies for eight tetranucleotide short tandem repeat (STR) loci-CSF1PO, TPOX, TH01, F13A01, FESFPS, vWA, F13B, LPL-were obtained from a population sample of 105-122 unrelated individuals born in Transylvania and Banat (Romania).
Collapse
Affiliation(s)
- A Anghel
- Biochemistry Department, "Victor Babes" University of Medicine and Pharmacy, Piata Eftimie Murgu No 2, 1900 Timisoara, Romania.
| | | | | | | | | | | | | |
Collapse
|
39
|
|
40
|
Döll G, Anghel A, Baumann JR, Bucher E, Ramirez AP, Range KJ. Structural and Magnetic Properties of the Ternary Manganese Compound Semiconductors MnAl2Te4, MnIn2Te4, and MnIn2Se4. ACTA ACUST UNITED AC 1991. [DOI: 10.1002/pssa.2211260127] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
41
|
Lupaşcu EG, Anghel A, Bănică A, Dobrescu G, Niculescu C, Zaharia V. [Value of the ether-soluble bilirubin test in positive and differential diagnosis of epidemic hepatitis]. Microbiol Parazitol Epidemiol (Bucur) 1966; 11:443-447. [PMID: 5975910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|